Mumbai: Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a ...
Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based products, and the Tokyo Metropolitan Institute of Medical Science (TMIMS), today announce their ...
See how Concept Life Sciences accelerated early clinical trials by quickly transferring a client’s process and completing GMP ...
This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...
Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru.
2d
AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for "Bubble Baby Disease"
AGC Biologics, your friendly CDMO expert, announced an agreement to provide comprehensive development and manufacturing for Rarity PBC's gene therapy.
Syngene International plans to add bioconjugation suite for end-to-end ADC development: Our Bureau, Bengaluru Thursday, October 23, 2025, 15:15 Hrs [IST] Syngene International, a ...
Syngene International, a global CRDMO, is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru. With this new capability, Syngene will offer fully integrated, ...
Syngene expands its Biologics facility in Bengaluru, adding ADC bioconjugation to accelerate development timelines and enhance services.
Orion and Abzena announce exclusive commercial license for Abzena’s monoclonal antibodies: San Diego, California Friday, October 24, 2025, 10:00 Hrs [IST] Abzena, the leading en ...
AI refers to a machine-based system and ML refers to a set of techniques that can be used to train AI algorithms (2) so ML ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback